Q&A: Infections from over-the-counter artificial tears—implications for patients and clinicians

The Food and Drug Administration (FDA) has recalled dozens of over-the-counter eye drops—artificial tears—in 2023 due to contamination and unsafe manufacturing practices. Four deaths from sepsis, 14 cases of vision loss and more than 80 infections were reported as of May. Most of the patients reported using EzriCare Artificial Tears, which was recalled in February.